TRUST Bio-sonics, founded in 2013, is a pharmaceutical company focused on drug developments, specializing in the developments of the products related to early diagnosis and treatment of cancers. Our R & D team includes the experts from the top research institutions of medical imaging and drug delivery. The core technology is the microbubble-based ultrasound drug delivery system (UDDS), through using focused ultrasound to rupture microbubbles to locally release drug molecules on the targeted region. The UDDS is designed to reduce side effects and increase drug absorption. TRUST further has the strong experiences in liposomal formulations. We aim to integrate both bubble and liposome technologies to offer new treatment solutions. The pilot production and analysis laboratories have been built in Hsinchu Biomedical Science Park for early developments of new products. For the main product line, TRUST has contracted with a PIC/S GMP-certificated CMO for the followed mass production. Our core vision is to provide patients with early diagnosis and treatment solutions, improving the health status of patients and providing better living quality. " Lead innovations and create values " is the goal of TRUST Bio-sonics.